Skip to main content
. 2019 Feb 13;11(3):1065–1068. doi: 10.18632/aging.101822

Figure 3.

Figure 3

Therapeutic targeting of e-CSCs. Experimentally, both an OXPHOS inhibitor (Diphenyleneiodonium; DPI) and a CDK4/6 (Ribociclib) inhibitor were effective in abrogating the 3D-propagation of e-CSCs.